The metastasis suppressive functions of CD82 have been reported to be abrogated by the splicing of the CD82 gene [50,51], where the CD82 spliced variant was observed to enhance cell migration and proliferation, concomitant with the activation of Src kinase in MDA-MB-231 breast cancer cells [50]. Here, CD82 is linked to breast cancer.